| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
YWHAE |
YWHAE: 14-3-3 protein epsilon |
5.282 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
YWHAE |
YWHAE: 14-3-3 protein epsilon |
5.282 |
Evidence |
|
| CTGF |
CTGF, CCN2, HCS24: Connective tissue growth factor precursor |
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
5.282 |
Evidence |
|
| FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
EP300 |
IPI00478752 |
5.282 |
Evidence |
|
| FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
NACA |
NACA, HSD48: Nascent polypeptide-associated complex subunit alpha |
5.282 |
Evidence |
|
| FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
TDG |
TDG: G/T mismatch-specific thymine DNA glycosylase |
5.282 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
TSHR |
IPI00386365 |
5.282 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
NPR2 |
NPR2, ANPRB: Atrial natriuretic peptide receptor B precursor |
5.282 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
TGFBR2 |
TGFBR2: TGF-beta receptor type-2 precursor |
5.282 |
Evidence |
|
| HPN |
HPN, TMPRSS1: Serine protease hepsin |
GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
5.282 |
Evidence |
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
TCEB3 |
TCEB3, MSTP059: Transcription elongation factor B polypeptide 3 |
5.282 |
Evidence |
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
IEF-SSP-9502 |
PWP1: Periodic tryptophan protein 1 homolog |
5.282 |
Evidence |
|
| VAMP4 |
VAMP4: Vesicle-associated membrane protein 4 |
VAMP3 |
VAMP3, SYB3: Vesicle-associated membrane protein 3 |
5.282 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CRK |
IPI00399054 |
5.282 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
SHC1 |
SHC1, RP11-307C12.1-001, hCG_1997126: SHC |
5.282 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
EVL |
IPI00218245 |
5.282 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
MTHFD1 |
MTHFD1, MTHFC, MTHFD: C-1-tetrahydrofolate synthase, cytoplasmic |
5.282 |
Evidence |
|
| AKR7A2 |
AKR7A2, AFAR, AFAR1, AKR7: Aflatoxin B1 aldehyde reductase member 2 |
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
5.282 |
Evidence |
|
| AKR7A2 |
AKR7A2, AFAR, AFAR1, AKR7: Aflatoxin B1 aldehyde reductase member 2 |
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
5.282 |
Evidence |
|
| SGK |
SGK, SGK1: Serine/threonine-protein kinase Sgk1 |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
5.282 |
Evidence |
|
| RRM1 |
RRM1, RR1: Ribonucleoside-diphosphate reductase large subunit |
RRM2B |
RRM2B, P53R2: Ribonucleoside-diphosphate reductase subunit M2 B |
5.282 |
Evidence |
|
| RHOG |
RHOG, ARHG: Rho-related GTP-binding protein RhoG precursor |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
5.28 |
Evidence |
|
| CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
STAT3 |
|
5.28 |
Evidence |
|
| ETV1 |
ETV1, ER81: ETS translocation variant 1 |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
5.28 |
Evidence |
|
| YWHAQ |
YWHAQ: 14-3-3 protein theta |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
5.28 |
Evidence |
|